Mucocutaneous Lymph Node Syndrome

Mucocutaneous Lymph Node Syndrome is the indication for 2 drugs in DrugBank. It is covered by 4 curated, structured indications.

Also known as
Kawasaki's disease · Kawasaki Disease · Kawasaki Syndrome

Resolves to

Vocabularies
MeSHM0014162ICD-10M30.3SNOMED CT155444003MedDRA10000747UMLSC0026691

What you can answer from here — as of November 22, 2026

2Indicated drugsWith each drug's targets and mechanism
Listed above
4Structured indicationsPopulation, line of therapy, route and combination as fields, not prose
Sign in
35Clinical trialsPhase, status and sponsor resolved per trial
Sign in

Which approved drugs for Mucocutaneous Lymph Node Syndrome share a target, and which companies have late-stage candidates against it?

Create a free account or log in to explore the full data card.

Create Account